Meracaptaz 50 mg contains Melphalan, an alkylating anticancer medicine used in the treatment of certain blood cancers and other selected malignancies. It works by damaging the DNA of rapidly dividing cancer cells, helping to slow or stop their growth. Melphalan tablets are prescribed only under the supervision of an experienced oncologist due to the risk of severe bone marrow suppression and the need for close monitoring. Key Benefits Helps treat specific cancers by inhibiting cancer cell growth. Oral tablet for convenient administration when prescribed. Commonly used in established chemotherapy protocols. May be used alone or in combination with other anticancer medicines. Treatment is individualized based on the patient's condition and response. Indications Meracaptaz (Melphalan Tablets) may be prescribed for: Multiple myeloma Ovarian cancer Other oncology indications as determined by the treating oncologist and local treatment guidelines. How It Works Melphalan belongs to the alkylating agent class of chemotherapy medicines. It forms cross-links with DNA, preventing cancer cells from replicating and dividing, which ultimately leads to cancer cell death. Dosage & Administration Take only as prescribed by your oncologist. Swallow the tablet whole with water. The dose depends on the type of cancer, body condition, and blood test results. Regular blood tests are essential during treatment to monitor blood cell counts and organ function. Do not change or stop the medication without medical advice. Possible Side Effects Common side effects may include: Low white blood cell count (neutropenia) Low platelet count (thrombocytopenia) Anemia Nausea and vomiting Loss of appetite Mouth sores Fatigue Increased risk of infections Seek immediate medical attention if you develop fever, unusual bleeding, severe bruising, persistent vomiting, or signs of a serious infection.

Melphalaz (Melphalan Injection 50 mg) is a chemotherapy medicine containing Melphalan, an alkylating agent used in the treatment of certain cancers. It works by damaging the DNA of rapidly dividing cancer cells, preventing their growth and multiplication. Melphalaz is administered by qualified healthcare professionals in hospitals or specialized oncology centers under the supervision of an experienced oncologist. Key Benefits Effective chemotherapy for selected blood cancers and other malignancies. Helps slow or stop the growth of cancer cells. Used as part of standard oncology treatment protocols. May be used alone or in combination with other anticancer medicines. Administered under strict medical supervision for optimal safety and efficacy. Indications Melphalaz (Melphalan Injection 50 mg) may be prescribed for: Multiple myeloma Ovarian cancer High-dose conditioning therapy before stem cell or bone marrow transplantation Other malignancies as determined by the treating oncologist How It Works Melphalan belongs to the alkylating agent class of chemotherapy drugs. It binds to the DNA of cancer cells, causing cross-linking that interferes with DNA replication and cell division. This ultimately leads to cancer cell death and helps control tumor growth. Dosage & Administration Administered only by trained healthcare professionals. The dosage is based on the patient's body weight, medical condition, laboratory values, and treatment protocol. Given by intravenous (IV) injection or infusion as directed by the oncologist. Patients should undergo regular blood tests during treatment to monitor blood cell counts and organ function. Possible Side Effects Common side effects may include: Low white blood cell count (neutropenia) Low platelet count (thrombocytopenia) Anemia Nausea and vomiting Mouth sores (mucositis) Loss of appetite Fatigue Increased risk of infection Hair thinning or hair loss (less common) Seek immediate medical attention if you develop fever, severe bleeding, difficulty breathing, allergic reactions, or signs of serious infection.

Lenvitib Cap contains Lenvatinib, an oral targeted anticancer medicine classified as a multi-kinase inhibitor (TKI). It works by blocking proteins that promote tumor growth and the formation of new blood vessels (angiogenesis), helping to slow or stop the progression of certain cancers. Lenvitib Capsules are prescribed by oncologists for the treatment of selected advanced or metastatic cancers, either alone or in combination with other anticancer therapies. Key Benefits Helps slow the growth and spread of cancer cells. Inhibits blood vessel formation that supplies tumors. Oral capsule for convenient at-home treatment as prescribed. Used in multiple cancer types based on clinical guidelines. Can be used alone or in combination with immunotherapy or other anticancer medicines in appropriate patients. Indications Lenvitib (Lenvatinib) Capsules may be prescribed for: Differentiated thyroid cancer (DTC) that is radioactive iodine-refractory. Advanced renal cell carcinoma (kidney cancer), in combination with other medicines where indicated. Hepatocellular carcinoma (liver cancer). Advanced endometrial cancer in combination therapy, as recommended by the treating oncologist. Other approved oncology indications according to local prescribing guidelines. How It Works Lenvatinib blocks multiple receptor tyrosine kinases, including VEGFR, FGFR, PDGFR, RET, and KIT. By inhibiting these pathways, it reduces tumor blood supply and slows cancer cell growth and spread. Dosage & Administration Take exactly as prescribed by your oncologist. Swallow the capsule whole with water, with or without food. Take it at the same time each day. Do not change the dose or stop treatment without medical advice. If a dose is missed, follow your healthcare provider's instructions. Possible Side Effects Common side effects may include: High blood pressure Fatigue Diarrhea Decreased appetite Weight loss Nausea or vomiting Mouth sores Hand-foot syndrome Protein in urine Seek immediate medical attention if you experience severe bleeding, chest pain, severe headache, shortness of breath, or signs of liver or kidney problems.